Trevena Shares Outstanding 2012-2021 | TRVN

Trevena shares outstanding from 2012 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Trevena Annual Shares Outstanding
(Millions of Shares)
2020 128
2019 92
2018 74
2017 59
2016 52
2015 44
2014 25
2013 1
2012 1
2011 1
Trevena Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 163
2021-03-31 161
2020-12-31 128
2020-09-30 144
2020-06-30 111
2020-03-31 96
2019-12-31 92
2019-09-30 93
2019-06-30 92
2019-03-31 89
2018-12-31 74
2018-09-30 77
2018-06-30 70
2018-03-31 65
2017-12-31 59
2017-09-30 60
2017-06-30 58
2017-03-31 57
2016-12-31 52
2016-09-30 52
2016-06-30 52
2016-03-31 51
2015-12-31 44
2015-09-30 44
2015-06-30 41
2015-03-31 39
2014-12-31 25
2014-09-30 26
2014-06-30 26
2014-03-31 16
2013-12-31 1
2013-09-30 1
2013-06-30 1
2013-03-31 1
2012-12-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.183B $0.003B
Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of Prussia, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.460B 8.55
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.211B 20.68
Biohaven Pharmaceutical Holding (BHVN) United States $8.952B 0.00
Emergent Biosolutions (EBS) United States $2.717B 6.55
Arcus Biosciences (RCUS) United States $2.502B 0.00
Myovant Sciences (MYOV) United Kingdom $1.906B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.820B 0.00
Zymeworks (ZYME) Canada $1.088B 0.00
Ambrx Biopharma (AMAM) United States $0.513B 0.00
SQZ Biotechnologies (SQZ) United States $0.343B 0.00
Enzo Biochem (ENZ) United States $0.159B 15.57